View Author
dai: 152793968
scopus: 6603002415

Bergh, A.R.M. von

(Anne von Bergh)


leukemia patient aberration mutation expression procaspase myeloid leukemia deletion children chromosome protein study resistance type-i group childhood myeloid blood type-ii aberrations type-ii analysis sample event karyotype procaspase -2 expression lymphoblastic leukemia type-i aberrations 3-itd cytogenetic level caspase parp expression table figure probe prognostic t-lineage procaspase -2 apoptosi flt 3-itd npm 1 mutations jacobsen syndrome b-lineage lymphoblastic value frequency treatment syndrome factor cebpa outcome 11 q deletion drug resistance wt 1 mutations breakpoint adult jacobsen kit mutations survival j clin oncol 5- year cir chromosome 11 genet zimmermann m region number cancer 11 q deletions apoptotic array feature result subtype signal wt 1 mutation netherland blood cell count trial den boer ml 5- year pos




3 Most Recent Publications

Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia (Article)
Balgobind, B.V. Hollink, I.H.I.M. Zemanová, Z. Stary, J. Cayuela, J.M. Baruchel, A. Creutzig, U. Reinhardt, D. Pieters, R. Michel Zwaan, C. Heuvel-Eibrink, M.M. van den Arentsen-Peters, S.T.C.J.M. Zimmermann, M. Harbott, J. Beverloo, H.B. Bergh, A.R.M. von Cloos, J. Kaspers, G.J. Haas, V. de
2011-10-01
Interstitial 11q deletion derived from a maternal ins(4;11)(p14;q24.2q25): A patient report and review (Article)
Zutven, L.J.C.M. van Bever, Y. van Nieuwland, C.C.M. van Huijbregts, G.C.M. Opstal, D. van Bergh, A.R.M. von Corel, L.J.A. Tibboel, D. Wouters, C.H. Poddighe, P.
2009-07-01
Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia (Article)
Holleman, A. Boer, M.L. den Kazemier, K.M. Beverloo, H.B. Bergh, A.R.M. von Janka-Schaub, G.E. Pieters, R.
2005-01-01